← Back to headlines
Bayer Acquires Perfuse for $2.45 Billion to Boost Eye Drug Pipeline
Bayer announced its intention to acquire Perfuse for up to $2.45 billion, a move aimed at strengthening its pipeline of eye-related pharmaceutical drugs.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
